Analyst Price Targets — PROF
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 27, 2026 5:05 pm | Strong Buy | Raymond James | $11.00 | $7.33 | TheFly | Profound Medical upgraded to Strong Buy from Outperform at Raymond James |
| January 7, 2026 1:42 pm | — | Lake Street | $12.00 | $7.95 | TheFly | Profound Medical price target raised to $12 from $11 at Lake Street |
| December 2, 2024 1:39 pm | Ben Haynor | Loop Capital Markets | $17.00 | $8.03 | StreetInsider | Profound Medical Corp. (PROF) PT Raised to $17 at Lake Street Capital Markets |
| July 23, 2024 8:41 am | Ben Haynor | Lake Street | $16.50 | $10.28 | TheFly | Profound Medical initiated with a Buy at Lake Street |
| July 15, 2024 5:02 pm | Rick Wise | Stifel Nicolaus | $12.00 | $9.15 | StreetInsider | Stifel Upgrades Profound Medical Corp. (PROF) to Buy |
Latest News for PROF
TORONTO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, announced today that management will participate in the Lake Street Capital Markets “BIG10” Conference on September 10, 2026 in New York City.
TORONTO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the appointment of Richard Fabian as its new President, effective immediately.
Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day Most recent TDC software provides a potential roadmap for customers to easily achieve up to 6 TULSA Procedures™ per system per day
TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, today announced the promotion of Matthew Sobczyk from Corporate Controller to Interim Chief Financial Officer, effective immediately. Mr. Sobczyk, who first joined Profound in 2020,…
A patient-centered initiative focused on education, connection, and support A patient-centered initiative focused on education, connection, and support
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for PROF.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.